At the Cutting Edge of Ophthalmology: Exploring the Research of Associate Professor Simon Skalicky
Introduction
Vision is one of our most precious senses, and few understand this better than Associate Professor Simon Skalicky—an Australian ophthalmologist whose clinical expertise is matched by a deep commitment to research and innovation. Based in Melbourne, Dr. Skalicky is not only a skilled cataract and glaucoma surgeon but also a prolific researcher whose work is influencing the global direction of eye care.
From pioneering technology-driven diagnostic solutions to publishing widely on the lived experience of glaucoma patients, Dr. Skalicky’s research aims to close the gap between technical excellence and real-world patient outcomes. This article examines his most significant recent contributions, highlighting how they are transforming both ophthalmology and the lives of those affected.
Research That Puts the Patient First: Quality of Life in Glaucoma Care
While many medical studies focus on physical outcomes or clinical markers, Dr. Skalicky has directed significant attention to how patients feel about their care. His research into patient-reported outcome measures (PROMS) in glaucoma has helped shape a more human-centred understanding of the condition.
Using custom-designed questionnaires and interviews, he has explored the emotional, functional, and social impacts of glaucoma, especially the ways it affects mobility, independence, and daily confidence. These findings have informed more empathetic clinical practice and highlighted the need for clinicians to view glaucoma management not only through the lens of intraocular pressure readings but through a broader psychosocial perspective.
Investigating Genetic Links: A Case of Hereditary Spherocytosis and Glaucoma
In a lesser-known yet important piece of work, Dr. Skalicky co-authored a study that examined a potential connection between hereditary spherocytosis, a rare blood disorder, and glaucoma-related optic nerve damage.
The paper posited that compromised blood supply to the optic nerve—possibly linked to the abnormal shape of red blood cells in spherocytosis—could contribute to the onset or progression of glaucoma. Though early-stage and exploratory, the study opened the door for more interdisciplinary conversations between haematology and ophthalmology, particularly around vascular health and nerve preservation.
Revolutionising Glaucoma Diagnosis with Eyeonic Technology
One of Dr. Skalicky’s most innovative projects is the creation of Eyeonic, a digital platform that brings accessible, AI-supported glaucoma screening to people who may otherwise go undiagnosed.
Eyeonic is a cloud-based visual field testing tool that allows patients to undergo standardised assessments using computers or tablet devices. Unlike conventional visual field machines, which are typically bulky and expensive, Eyeonic’s solution is portable, scalable, and user-friendly. It has been deployed in both Australian and international clinical settings, including outreach work in over twenty countries in every continent of the globe.
This development is especially vital for remote or resource-limited communities where access to regular eye exams is restricted. By democratising glaucoma screening, Eyeonic represents a leap forward in preventive ophthalmology.
Glaucoma Surgical Innovation: Laser Therapies and MIGS
As part of his ongoing contribution to surgical techniques, Dr. Skalicky has published extensively on the effectiveness of minimally invasive glaucoma surgery (MIGS) and Selective Laser Trabeculoplasty (SLT).
His research supports the growing body of evidence that SLT can serve as a first-line treatment for open-angle glaucoma, either reducing or eliminating the need for long-term medication in many patients. Additionally, he has investigated how combining MIGS devices (such as iStent) with cataract surgery can offer dual benefits, lowering intraocular pressure while restoring vision.
These studies have helped refine treatment protocols, ensuring that patients receive the most appropriate, least invasive interventions at the right time in their care journey.
Immersive Diagnostics: Using Virtual Reality to Measure Real-Life Impact
Bringing tech innovation even further into the clinical setting, Dr. Skalicky explored the potential of smartphone-compatible virtual reality headsets to assess how glaucoma limits day-to-day tasks.
In one experimental study, patients performed everyday simulations, such as navigating a room or identifying objects, while wearing VR headsets. These tasks were designed to measure “functional vision” as it relates to real-life experiences rather than chart-based vision alone. This form of assessment could become a more accurate way to measure the true burden of disease for glaucoma patients.
The result is a more holistic approach to eye care, where treatment outcomes are measured not only by numerical metrics but also by real improvements in lifestyle and autonomy.
A Global Voice in Eye Health Advocacy and Education
Dr. Skalicky’s influence extends well beyond the walls of his Melbourne practice. He is a key contributor to international ophthalmology organisations, including Glaucoma Australia and the World Glaucoma Association. He has also collaborated on AI-based care systems that could support underserved populations worldwide.
One of his standout educational contributions is his textbook on ocular and visual physiology, which is now widely used by ophthalmology students across Australia and New Zealand. His roles as a university lecturer, textbook author, and international speaker all point to a career dedicated not only to practising medicine, but also improving it for generations to come.
Conclusion
Associate Professor Simon Skalicky is not just treating eye conditions—he’s advancing the very way we understand, diagnose, and manage them. From patient-centred outcomes in glaucoma to innovative digital diagnostic tools and global outreach efforts, his work reflects a rare blend of compassion, creativity, and clinical expertise.
As ophthalmology continues to evolve through data, devices, and digital health, Dr. Skalicky’s research remains at the cutting edge, making eye care more accessible, more accurate, and more humane.
For a deeper look at his clinical services or to explore research publications, visit www.drsimonskalicky.com.au.